FDA and NIH launch Critical Path for Rare Neurodegenerative Diseases – a public-private partnership aimed at advancing the understanding of rare neurodegenerative diseases and fostering the development of treatments.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5612tuz
No comments:
Post a Comment